Detection of oseltamivir resistance during treatment of 2009 H1N1 influenza virus infection in immunocompromised patients: utility of cycle threshold values of qualitative real-time reverse transcriptase PCR

J Clin Microbiol. 2010 Nov;48(11):4326-8. doi: 10.1128/JCM.01190-10. Epub 2010 Sep 15.

Abstract

Two immunocompromised patients with 2009 H1N1 influenza pneumonia had viral shedding for over 5 weeks despite therapy with oseltamivir. Declining or persistently low cycle threshold values noted on serial qualitative real-time reverse transcriptase PCR (rRT-PCR) of respiratory specimens implied increasing viral load and probable drug resistance. Oseltamivir resistance was later confirmed by pyrosequencing.

Publication types

  • Case Reports

MeSH terms

  • Antiviral Agents / administration & dosage
  • Antiviral Agents / pharmacology*
  • Drug Resistance, Viral*
  • Humans
  • Immunocompromised Host
  • Influenza A Virus, H1N1 Subtype / drug effects*
  • Influenza A Virus, H1N1 Subtype / genetics
  • Influenza A Virus, H1N1 Subtype / isolation & purification
  • Influenza, Human / drug therapy*
  • Influenza, Human / virology
  • Male
  • Microbial Sensitivity Tests
  • Middle Aged
  • Oseltamivir / administration & dosage
  • Oseltamivir / pharmacology*
  • Reverse Transcriptase Polymerase Chain Reaction / methods*
  • Sequence Analysis, DNA
  • Sputum / virology
  • Time Factors
  • Viral Load
  • Virus Shedding

Substances

  • Antiviral Agents
  • Oseltamivir